ArticlePharmacoEconomics2007
Modelling cost effectiveness of insulin glargine for the treatment of type 1 and 2 diabetes in Canada.
Daniel T Grima et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled ittrialcites it